Roundtable for the Development of Drugs and Vaccines Against Acquired Immuno Deficiency Syndrome (AIDS).
NATIONAL ACADEMY OF SCIENCES WASHINGTON DC
Pagination or Media Count:
The Roundtable for the Development of Drugs and Vaccines Against AIDS was established in 1988 by the Institute of Medicine. Composed of leaders from government, the pharmaceutical industry, academia, and the public, its mission is to identify and help resolve impediments to the speedy availability of safe and effective drugs and vaccines for human immunodeficiency virus HIV infection and acquired immune deficiency syndrome AIDS. The Roundtable accomplishes its mission through regular meetings of its membership, during which urgent issues are identified and discussed, as well as through public conferences and workshops that explore scientific and policy matters central to the development of AIDS therapeutics. The conference program was broken down into seven sessions covering 1 Historical Perspective - The Advent of AIDS Broadening Participation Accelerating the Pace of Drug Development 2 Rights and Responsibilities 3 Evaluation of Expanded Access Programs 4 Creativity in Clinical Trials 5 Drug Innovation and the Pharmaceutical Industry 6 Third-Party PayersHealth Insurance, Medicaid, Medicare 7 Improving Access to Care.
- Medicine and Medical Research